A Phase 3 Trial of Brepocitinib in Dermatomyositis
Original Article
R.A. Vleugels, J.J. Paik, I.B. Ventura, A.R. Mangold, P.C. Gandiga, A. Haemel, H. Chinoy, Y.M. Hussain, K. Sivakumar, Z. Griger, E.B. Lee, F. Bozan, C.-Y. Hsu, A. Femia, M.M. Dimachkie, M.S. Min, T. Mozaffar, C. Charles-Schoeman, D.R. Fernandez, O. Onajin, R. Campanilho-Marques, G. Marder, F. Ernste, E. Schiopu, J. Sluzevich, D. Pearson, S. Lindsey, M. Luggen, M.R. Bubb, E. Boh, R. Maganti, L. Heinlen, K.S. Shaw, M.D. Cascino, P.N.M. Jr., Jr., J. Vencovsky, A.P. Fernandez, D. Fiorentino, L. Christopher-Stine, V.P. Werth, and R. Aggarwal
N Engl J Med 2026;394:1883-1893
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.

Facebook
X
LinkedIn
Forward